Futura Medical PLC
28 February 2005
RNS Release 28 February 2005
Futura Medical change in Nominated Adviser and Broker
Futura Medical plc ('Futura'), the AIM-quoted pharmaceutical drug and medical
device group that develops innovative products for the sexual healthcare market,
announces the following adviser appointments with immediate effect:
Nominated Adviser
Canaccord Capital (Europe) Limited
Joint brokers
Collins Stewart Limited
Canaccord Capital (Europe) Limited remains joint broker.
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 845 670
Canaccord Capital (Europe) Ltd
Stephen Rowntree Tel: +44 (0)20 7518 7371
Collins Stewart Ltd
Chris Howard Tel: + 44 (0) 20 7523 8350
Media enquiries:
Abchurch
Peter Curtain / Alex Tweed Tel: +44 (0) 20 7398 7700
mailto: alex.tweed@abchurch-group.com www.abchurch-group.com
www.futuramedical.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange DGGUI